Actively Recruiting
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Led by Chinese PLA General Hospital · Updated on 2026-03-20
3772
Participants Needed
1
Research Sites
300 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;
CONDITIONS
Official Title
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years, any gender
- Papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
- Largest tumor diameter 2.0 cm or less
- No clinical or imaging evidence of extrathyroidal extension, lymph node metastasis, or distant metastasis on ultrasound, neck and chest CT
- Follow-up period of at least 12 months
You will not qualify if you...
- Evidence of aggressive papillary thyroid carcinoma or other thyroid cancer by biopsy
- History of neck radiation
- History of thyroid surgery
- Coagulation disorder
- Serious heart, respiratory, liver, or renal failure
- Dysfunction of the vocal cord on the opposite side
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, China
Actively Recruiting
Research Team
L
Lin Yan, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here